External pituitary irradiation as a cause of TRH deficiency in patients with pituitary adenomas.
AffiliationDepartments of Endocrinology and Radiotherapy, Christie Hospital and Holt Radium Institute, Manchester M20 9BX
MetadataShow full item record
AbstractThe influence of external pituitary irradiation (XRT) on thyrotroph function and PRL secretion was studied in twenty-five patients with pituitary adenomas, of whom eight had acromegaly. Twenty-one patients had undergone subtotal operative removal of their adenomas 8-190 weeks (median 12 weeks) before XRT. Following irradiation there was a significant reduction in peak serum TSH levels in response to i.v. TRH (P less than 0.05, compared with before XRT). Peak TSH levels returned to normal at 3 months. Similarly a transient reduction in TRH-stimulated beta-TSH release was observed. Serum T3 and T4 concentrations also fell after XRT, the levels at 3 months being significantly lower than control values (P less than 0.02), though no difference was seen at 6 and 12 months. A delayed (hypothalamic) serum TSH response to TRH (60 greater than 20-min level) developed at 6 months. In contrast, PRL concentrations (basal and TRH stimulated) were not altered during the 12 months following XRT. These findings demonstrate that thyrotroph function can be transiently impaired following external pituitary irradiation. None of the patients studied required T4 replacement therapy. The development of a delayed TSH response to i.v. TRH may indicate endogenous TRH deficiency. It was not associated with supra-sellar tumour enlargement in our patients and may be due to hypothalamic damage by irradiation.
CitationExternal pituitary irradiation as a cause of TRH deficiency in patients with pituitary adenomas. 1983, 18 (2):201-9 Clin Endocrinol
- Effect of thyrotrophin releasing hormone (TRH) in patients with pituitary disorders.
- Authors: Lindholm J, Dige-Petersen H, Hummer L, Rasmussen P, Korsgaard O
- Issue date: 1977 Jul
- The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.
- Authors: Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueta Y, Adachi T, Urabe K, Tanaka T, Yoshida A, Hori T
- Issue date: 1988 Apr
- Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
- Authors: Kaplan MM, Taft JA, Reichlin S, Munsat TL
- Issue date: 1986 Oct
- Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
- Authors: Frey HM, Haug E
- Issue date: 1977 Aug
- The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
- Authors: Spencer CA, Greenstadt MA, Wheeler WS, Kletzky OA, Nicoloff JT
- Issue date: 1980 Oct